You are here

  • Home
  • Archive
  • Volume 6, Issue 4
  • Twelve-year follow-up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer

Article metrics

Article menu
Original Article
Twelve-year follow-up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer

 

Online download statistics by month:

Online download statistics by month: February 2019 to February 2023

AbstractFullPdf
Feb 2019600
Mar 2019400
May 2019200
Jun 2019400
Jul 2019400
Aug 2019200
Sep 2019500
Oct 2019300
Nov 2019200
Dec 2019200
Jan 2020800
Feb 2020200
Apr 2020200
May 20201000
Jun 2020400
Jul 20201000
Aug 2020200
Sep 2020600
Oct 2020400
Dec 2020200
Jan 2021400
Feb 2021400
Oct 2021600
Dec 2021200
Jan 2022800
Feb 2022600
Mar 20221800
Apr 20221400
May 20223400
Jun 20222800
Jul 20221000
Aug 20224000
Sep 20223200
Oct 20223400
Nov 20221600
Dec 2022800
Jan 2023600
Feb 20236200
Total41600